Produkty 438244-33-8

CAS 438244-33-8 występuje w naszej ofercie pod nazwami: 6α-Hydroxynorethisterone, 6alpha-Hydroxynorethisterone, (6S,8R,9S,13S,14S,17R)-17-Ethynyl-6,17-dihydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta(A)phenanthren-3-one. Oferty producentów: TRC, Mikromol, Biosynth. Dostępne opakowania: 25mg, 50mg, 100mg.

6α-Hydroxynorethisterone
TRC
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
6alpha-Hydroxynorethisterone
Mikromol
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
(6S,8R,9S,13S,14S,17R)-17-Ethynyl-6,17-dihydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta(A)phenanthren-3-one
Biosynth
  • opakowanie: 50mg, 25mg, 100mg
  • Warianty: 3
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(6S,8R,9S,10R,13S,14S,17R)-17-ethynyl-6,17-dihydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 438244-33-8) to związek chemiczny o wzorze sumarycznym C20H26O3 i masie molowej 314.4 g/mol. Nazwa systematyczna IUPAC: (6S,8R,9S,10R,13S,14S,17R)-17-ethynyl-6,17-dihydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: RONQVEAZNZIVHW-KLEXHFHZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC20H26O3
Masa molowa314.4 g/mol
Nazwa IUPAC(6S,8R,9S,10R,13S,14S,17R)-17-ethynyl-6,17-dihydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyRONQVEAZNZIVHW-KLEXHFHZSA-N
SMILESC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4[C@H](C[C@H]3[C@@H]1CC[C@]2(C#C)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (6alpha,17alpha)-6,17-Dihydroxy-19-norpregn-4-en-20-yn-3-one, 6alpha-Hydroxynorethisterone, (6?,17?)-6,17-Dihydroxy-19-norpregn-4-en-20-yn-3-one, Norethindrone 6-alpha-Hydroxy Impurity
Powiązane formy tego związku
(6R,8R,9S,10R,13S,14S,17R)-17-ethynyl-6,17-dihydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one C20H26O3
Izomery (ten sam wzór sumaryczny)
(8S,13S,14S)-13-methylspiro[1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,2'-1,3-dioxolane]-17-one C20H26O3
(8R,9S,10R,13S,14S)-6-(hydroxymethyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione C20H26O3
2-tert-butyl-1-[2-(4-methoxyphenoxy)ethoxy]-4-methylbenzene C20H26O3
trans-(2R,3S)-2-ethyl-3-hydroxy-2-[(2E)-2-(6-methoxy-3,4-dihydro-2H-naphthalen-1-ylidene)ethyl]cyclopentan-1-one C20H26O3
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid C20H26O3
(8S,13S,14S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one C20H26O3
[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate C20H26O3
(8S,13S,14S,17S)-17-acetyl-17-hydroxy-13-methyl-1,2,4,6,7,8,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one C20H26O3
(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid C20H26O3
(1S,4S,12S,13R,16R,17R)-17-(hydroxymethyl)-12-methyl-8-oxapentacyclo[14.2.1.01,13.04,12.05,9]nonadeca-5(9),6,10-trien-17-ol C20H26O3
(5S,8R,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-2,4,5,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,6-dione C20H26O3